Recent Articles

March 10, 2017 7:00 am
Kenny Walter, Digital Reporter
The compound could boost an enzyme called NMNAT2.
March 9, 2017 8:48 am
Samuel Falsetti, Ph.D., Head of Medical Strategy and Product Innovation, Cambridge Biomarketing
Rapid whole genome sequencing. Gene editing. RNAi. CAR-T. The list goes on.
March 8, 2017 8:39 am
Christopher J. Reinhard, CEO, Angionetics
The human heart has an innate capacity to remodel in response to advancing coronary artery disease.
March 7, 2017 3:00 pm
Kavita Rainova, MSc, Senior Healthcare Analyst, GlobalData
Overall, biosimilars will account for 23% of the market by 2025.
March 7, 2017 2:46 pm
Ryan Bushey
The fallout from Mylan’s EpiPen pricing controversy appears to be taking a toll, according to a new analysis.
March 6, 2017 11:45 am
Ryan Bushey
GlaxoSmithKline could maintain its edge in the respiratory disease treatment space.
March 4, 2017 5:36 pm
Ryan Bushey
Eli Lilly’s grip on the psoriasis treatment space could be getting stronger.
March 3, 2017 1:32 pm
Ryan Bushey
Detailed information regarding these trials will be presented at the annual Academy of Dermatology Meeting in Orlando, Florida.
March 3, 2017 8:00 am
Israel Hodish, University of Michigan, The Conversation
There are many causes of insulin deficiency, but the most common is Type 2 diabetes.
March 3, 2017 8:51 am
GlobalData
Improving regulatory guidelines and government initiatives to develop the domestic pharmaceutical industry will contribute to a 13 percent spike in growth.
Subscribe to Drug Discovery & Development